Syndax Pharmaceuticals Inc SNDX
NASDAQ · United States · Health Technology
$18.22-0.58 (-3.09%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -0.55 | -0.45 | -22.9% | $72.79M | -8.3% | +3.5%$19.24→$19.92 |
| Q1 2026 | 2026-04-30 | -0.48 | -0.59 | +18.6% | — | — | -7.4%$20.63→$19.11 |
| Q4 2025 | 2026-02-26 | -0.78 | -0.64 | -21.9% | — | — | +4.6%$20.75→$21.71 |
| Q3 2025 | 2025-11-03 | -0.70 | -0.71 | +1.4% | — | — | +12.0%$13.70→$15.35 |
| Q2 2025 | 2025-08-04 | -0.83 | -1.01 | +17.8% | — | — | — |
| Q1 2025 | 2025-05-05 | -0.98 | -1.27 | +22.8% | — | — | — |
| Q4 2024 | 2025-03-03 | -1.10 | -0.23 | -378.3% | — | — | — |
| Q3 2024 | 2024-11-05 | -0.98 | -1.06 | +7.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.